NASDAQ · Healthcare · Biotechnology
Outlook Therapeutics, Inc.
OTLK
Outlook Therapeutics, Inc. CEO Robert Charles Jahr · Market cap $121.0M.
$0.65
-0.03 · -4.30%
52w hi $3.3952w lo $0.16
Off 52w high 77.7%
75
STRONG
Current InsiderScore
Corp · 90d
4
4 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
1 strong · 3 notable
Analyst consensus
Strong Buy
Avg PT $2.80
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 12 | Ghiath M. Sukhtian | Buy | 2,525,252 | $0.99 | +$2.50M | 68 | |
| Jul 29 | Faisal Ghiath Sukhtian | Buy | 95,398 | $1.05 | +$100K | 60 | |
| May 27 | Faisal Ghiath Sukhtian | Buy | 122,174 | $0.41 | +$50K | 72 | |
| May 26 | Kurt J Hilzinger | Buy | 400,000 | $0.44 | +$177K | 75 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug